Driehaus Capital Management’s Gilead Sciences GILD Stock Holding History

Driehaus Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$569K	Sell	4,085 -948	-19%	-$133K	﹤0.01%	333
2025 Q4	$618K	Buy	+5,033	New	+$612K	﹤0.01%	366
2024 Q1	–	Sell	-2,513	Closed	-$204K	–	410
2023 Q4	$204K	Buy	+2,513	New	+$196K	﹤0.01%	373
2022 Q1	–	Sell	-3,444	Closed	-$250K	–	409
2021 Q4	$250K	Buy	+3,444	New	+$237K	﹤0.01%	358
2020 Q2	–	Sell	-31,300	Closed	-$2.34M	–	425
2020 Q1	$2.34M	Buy	+31,300	New	+$2.16M	0.08%	220
2014 Q4	–	Sell	-44,292	Closed	-$4.71M	–	527
2014 Q3	$4.71M	Sell	44,292 -86,872	-66%	-$8.51M	0.18%	155
2014 Q2	$10.9M	Sell	131,164 -130,082	-50%	-$10.1M	0.35%	57
2014 Q1	$18.5M	Buy	261,246 +11,153	+4%	+$875K	0.58%	32
2013 Q4	$18.8M	Buy	250,093 +97,410	+64%	+$6.78M	0.68%	27
2013 Q3	$9.6M	Buy	152,683 +7,732	+5%	+$462K	0.37%	83
2013 Q2	$7.42M	Buy	+144,951	New	+$7.56M	0.32%	99

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Driehaus Capital Management's GILD Position: Q1 2026 in Review

Driehaus Capital Management reduced its Gilead Sciences (GILD) stake by 19% in Q1 2026, selling an estimated $133K and leaving 4,085 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Driehaus Capital Management first reported a position in GILD in Q2 2013 and has held it in 11 quarters since. The position peaked at $18.8M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Driehaus Capital Management held 4,085 shares of Gilead Sciences worth $569K as of Q1 2026.
Driehaus Capital Management sold 948 Gilead Sciences shares in Q1 2026, an estimated $133K.
Gilead Sciences made up ﹤0.01% of Driehaus Capital Management's portfolio in Q1 2026, its #333 holding.
Driehaus Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 11 quarters since.
Driehaus Capital Management's Gilead Sciences position peaked at $18.8M in Q4 2013.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.